These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids. Amaral AU, Wajner M. Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033 [Abstract] [Full Text] [Related]
15. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease. Morais FA, Lemos IS, Matiola RT, Freitas MLS, Alano CG, Cabral J, Wessler LB, Generoso JS, Scaini G, Réus GZ, Streck EL. Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251 [Abstract] [Full Text] [Related]
17. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease. Lemos IDS, Torres CA, Alano CG, Matiola RT, de Figueiredo Seldenreich R, Padilha APZ, De Pieri E, Effting PS, Machado-De-Ávila RA, Réus GZ, Leipnitz G, Streck EL. Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040 [Abstract] [Full Text] [Related]